(Q50577118)

15 March 2018

title

Interferon alpha monotherapy for chronic hepatitis C viral infection in thalassemics and hemodialysis patients. (English)

1 reference

15 March 2018

1 reference

R Artan

1

1 reference

15 March 2018

M Akcam

series ordinal

2

1 reference

15 March 2018

A Yilmaz

series ordinal

3

1 reference

15 March 2018

D Kocacik

series ordinal

4

1 reference

15 March 2018

publication date

1 December 2005

1 reference

15 March 2018

published in

Journal of Chemotherapy

1 reference

15 March 2018

volume

17

1 reference

15 March 2018

issue

6

1 reference

15 March 2018

page(s)

651-655

1 reference

15 March 2018

Interferon alpha in the treatment of chronic hepatitis C in children: a meta-analysis [correction of metanalysis].

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.651

Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.651

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.651

Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.651

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.651

Should patients with chronic hepatitis C who have normal ALT levels be treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.651

Response to interferon alfa-2b therapy in mutitransfused children with beta-thalassemia and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.651

Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.6.651

10.1179/JOC.2005.17.6.651

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018